Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP‐Activated Protein Kinase Signaling Pathway

BACKGROUND AND AIMS: Nonalcoholic fatty liver disease, especially nonalcoholic steatohepatitis (NASH), has become a major cause of liver transplantation and liver‐associated death. NASH is the hepatic manifestation of metabolic syndrome and is characterized by hepatic steatosis, inflammation, hepato...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Tian, Yu, Yang, Zhang, Jing, Li, Haonan, Weng, Qiqing, Jiang, Shuo, Tian, Song, Xu, Tonghao, Hu, Sha, Yang, Guizhi, Zhang, Yan, Wang, Weixuan, Wang, Lexun, Zhu, Qing, Rong, Xianglu, Guo, Jiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457150/
https://www.ncbi.nlm.nih.gov/pubmed/33576035
http://dx.doi.org/10.1002/hep.31749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457150/
https://www.ncbi.nlm.nih.gov/pubmed/33576035
http://dx.doi.org/10.1002/hep.31749

Ejemplares similares